Fennec Pharmaceutical

Fennec

Pharma

After 2 CRLs, FDA signs off on Fennec's hearing loss drug

Eighteen years after it was designated as an orphan drug, the FDA has approved Fennec's Pedmark for hearing loss induced by cisplatin chemotherapy.

Kevin Dunleavy Sep 21, 2022 10:10am

FDA Lab

FDA deals blow to hearing loss treatment for pediatric patients

Nov 29, 2021 11:12am